General Information of This Metabolic Reaction (MR) (ID: MR000492)
Formula
UGT2B7 ...
SVG example
Glucuronidation
Reactant Bupivacaine hydrochloride Product Buprenorphine glucuronide
Reactant Info Product Info
Metabolic Enzyme UDP-glucuronosyltransferase 2B7 (UGT2B7) DME Info
UDP-glucuronosyltransferase 1A1 (UGT1A1) DME Info
Metabolic Type Conjugation - Glucuronidation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000480 Bupivacaine hydrochloride 3'-OH-bupivacaine Oxidation - Hydroxylation Bupivacaine hydrochloride [1]
MR000478 Bupivacaine hydrochloride 4'-OH-bupivacaine Oxidation - Hydroxylation Bupivacaine hydrochloride [2]
MR000482 Bupivacaine hydrochloride Bupivacaine hydrochloride metabolite B1 Oxidation - Hydroxylation Bupivacaine hydrochloride [1]
MR000483 Bupivacaine hydrochloride Bupivacaine hydrochloride metabolite B4 Oxidation - Oxidation Bupivacaine hydrochloride [1]
MR000484 Bupivacaine hydrochloride Bupivacaine hydrochloride metabolite B5 Oxidation - Hydroxylation Bupivacaine hydrochloride [1]
MR000479 Bupivacaine hydrochloride Dihydroxybupivacaine Oxidation - Hydroxylation Bupivacaine hydrochloride [1]
MR000491 Bupivacaine hydrochloride Hydroxybuprenorphine Oxidation - Hydroxylation Buprenorphine hydrochloride [3]
MR000481 Bupivacaine hydrochloride N-desbutylbupivacaine Unclear Bupivacaine hydrochloride [1]
MR000485 Bupivacaine hydrochloride Sulfated hydroxy bupivacaine Conjugation - Sulfation Bupivacaine hydrochloride [1]
References
1 Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry Rapid Commun Mass Spectrom. 2012 Jun 15;26(11):1338-46. doi: 10.1002/rcm.6225.
2 Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos. 2000 Apr;28(4):383-5.
3 In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos. 2005 May;33(5):689-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.